2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

Welcome to the latest of our Eberhard F. Mammen award announcements. As noted many times previously, Thieme, the publisher of Seminars in Thrombosis & Hemostasis (STH), has created the Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards in honor of Eberhard Mammen ([ Fig. 1 ]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades (see [ Table 1 ] for relevant references). These awards began in 2009, under two categories; the current award details and conditions are as follows: Most Popular Article Awards: Awarded to the authors of the most popular articles published in Seminars in Thrombosis & Hemostasis . The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the Editor, Commentaries and Editorials, and previous award-winning articles are excluded from further consideration of these awards, which currently comprise two categories—one for “Open Access” articles, and another for a “General Category.” There are two major cash prizes of US$1,000 for each category. In addition, winners of the “General Category” awards are granted “free to download” status for these articles thereafter. Young Investigator Awards: Best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US$1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in Seminars in Thrombosis & Hemostasis . In general, previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the Senior Editors of STH. Any potential conflicts of interest are managed by first identifying these, and then excluding those with potential conflicts from voting. Finally, given the ongoing coronavirus disease 2019 (COVID-19) pandemic, many international congresses have become virtual meetings, and accordingly, virtual meeting presentations can also be considered for the award. Fig. 1 Eberhard F. Mammen (1930–2008). Table 1 Listing of relevant editorials published in the journal as related to the initiation of the Eberhard F. Mammen awards, as well as previous award announcements 1. Favaloro EJ. Welcome to a special issue of seminars in thrombosis and hemostasis—the closing issue for 2008. Semin Thromb Hemost 2008;34(8):693–696 2. Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008;34(8):703–708 3. Favaloro EJ. Welcome to the first issue of seminars in thrombosis and hemostasis for 2009. Semin Thromb Hemost 2009;35(1):1–2 4. Favaloro EJ. Winners of the inaugural Eberhard F. Mammen Award for Most Popular Article. Semin Thromb Hemost 2009;35(7):587–590 5. Favaloro EJ. 2009 Eberhard F. Mammen Young Investigator Award winners. Semin Thromb Hemost 2010;36(5):469–470 6. Favaloro EJ. Winners of the 2010 Eberhard F. Mammen Award for Most Popular Article during 2008–2009. Semin Thromb Hemost 2010;36(7):685–692 7. Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011;37(5):431–439 8. Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012;38(5):425–432 9. Favaloro EJ. 2013 Eberhard F. Mammen award announcements. Semin Thromb Hemost 39(6):567–574 10. Favaloro EJ. 2014 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2014;40(4):407–412 11. Favaloro EJ. 2014 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2014;40(7):718–723 12. Favaloro EJ. 2015 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2015;41(7):673–679 13. Favaloro EJ. 2015 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2015;41(8):809–815 14. Favaloro EJ. 2016 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2016;42(4):325–330 15. Favaloro EJ. 2016 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2017;43(3):235–241 16. Favaloro EJ. 2017 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2017;43(4):357–363 17. Favaloro EJ. 2017 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2018;44(2):81–88 18. Favaloro EJ. 2018 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2018;44(3):185–192 19. Favaloro EJ. 2018 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2019;45(2):123–129 20. Favaloro EJ. 2019 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2019;45(3):215–224 21. Favaloro EJ. 2019 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2020;46(2):105–113 22. Favaloro EJ. 2020 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2020;46(4):383–392 23. Favaloro EJ. 2020 Eberhard F. Mammen award announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2021;47(3):229–237 24. Favaloro EJ. 2021 Eberhard F. Mammen award announcements: Part I—Most Popular Articles. Semin Thromb Hemost 2021;47(5):467–476 Further details of the awards and the award winners are posted online (< https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 >), and previous award winner announcements are also available in print (see [ Table 1 ] for a listing of relevant editorials published in this journal as related to the initiation of the Eberhard F Mammen awards, as well as previous award announcements; these publications are also available for free download from the journal Web site: < https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 >). The winners of the 2021 Eberhard F Mammen awards for the most popular articles from Seminars in Thrombosis & Hemostasis for the period of 2018 to 2019 inclusive were announced in an earlier issue of the journal.[ 1 ] It is therefore with great pleasure that we would like to announce the winners of the latest round of Young Investigator Awards. As mentioned above, the Young Investigator Awards represent winners of the best presentation or meeting abstract by a young investigator—as presented or delivered to an international or large regional meeting (virtual meetings permissible) on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. There are additional considerations given that the nominees' presentations are not always seen by all of the possible award nominators, being drawn from the broader editorial team of the journal. The latest winners are identified below, with a running list of previous awardees, and the resulting publications in the journal, given in [ Table 2 ]. The latest awardees derived from recent meetings of the International Society on Thrombosis and Haemostasis (ISTH) and the American Society of Hematology (ASH). All meetings were held virtually or contained virtual presentations. Table 2 Eberhard F. Mammen Young Investigator Award winners from previous years Awardee Year awarded Publication arising Willem M. Lijfering 2009 Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost 2011;37(8):885–896 Salley Pels 2009 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost 2011;37(6):621–630 Adam Cuker 2010 Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia. Semin Thromb Hemost 2012;38(1):31–37 Giridhara Rao Jayandharan 2010 Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost 2012;38(1):64–78 Timea Szanto 2010 Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost 2012;38(1):55–63 Birgitta Salmela 2010 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost 2012;38(1):23–30 Pia Riittaa-Maria Siljander 2010 Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 2012;38(1):102–113 Romaric Lacroix 2011 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 2013;39(1):33–39 Brad McEwen 2011 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 2013;39(1):25–32 Neil A. Goldenberg 2011 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research. Semin Thromb Hemost 2013;39(1):10–14 Vivien Chen 2011 Chen VM. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin Thromb Hemost 2013;39(1):40–47 Joseph E. Italiano, Jr. 2011 Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb Hemost 2013;39(1):15–24 Vivian Xiaoyan Du 2012/2013 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014;40(1):72–80 Andrew Yee 2012/2013 Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost 2014;40(1):17–27 Sarah O'Brien 2012/2013 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb Hemost 2014;40(1):66–71 Veronica Flood 2012/2013 Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand disease. Semin Thromb Hemost 2014;40(1):41–48 Julie Tange 2012/2013 Tange JI, Grill D, Koch CD, Ybabez RJ, Krekelberg BJ, Fylling KA, Wiese CR, Baumann NA, Block DR, Karon BS, Chen D, Pruthi RK. Local verification and assignment of mean normal prothrombin time and international sensitivity index values across various instruments: recent experience and outcome from North America. Semin Thromb Hemost 2014;40(1):115–120 Kent Chapman 2012/2013 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present, and future. Semin Thromb Hemost 2014;40(1):34–40 Andreas Tiede 2014 Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia a: limitations, consequences, and challenges. Semin Thromb Hemost 2014;40(7):803–811 Wendy Lim 2014 Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost 2014;40(7):741–746 Susana Nobre Fernandes 2014 Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis approach on young adults with severe hemophilia. Semin Thromb Hemost 2014;40(7):785–789 Maria Elisa Mancuso 2014 Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool during by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb Hemost 2016;42(1):30–35 Coen Maas 2014 Tersteeg C, Fijnheer R, Deforche L, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C. Keeping von Willebrand factor under control: Alternatives for ADAMTS13. Semin Thromb Hemost 2016;42(1):9–17 Riten Kumar 2014 Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life factor concentrates and gene therapy. Semin Thromb Hemost 2016;42(1):18–29 Juraj Sokol 2015 Sokol J, Skerenova M, Jedinakova Z, Simurda T, Skornova I, Stasko J, Kubisz P. Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 2017;43(1):8–13 Ljubica Jovanović 2015 Jovanovic L, Antonijevic N, Novakovic T, Savic N, Terzic B, Zivkovic I, Radovanovic N, Asanin M. Practical aspects of monitoring of antiplatelet therapy. Semin Thromb Hemost 2017;43(1):14–23 Lucia Stanciakova 2015 Stanciakova L, Dobrotova M, Jedinakova Z, Duraj L, Skornova I, Korinkova L, Holly P, Danko J, Stasko J, Kubisz P. Monitoring of hemostasis and management of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal loss. Semin Thromb Hemost 2016;42(6):612–621 Tina Biss 2015 Biss TT. Venous thromboembolism in children: is it preventable? Semin Thromb Hemost 2016;42(6):603–611 Tobias Fuchs 2015 Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis? Semin Thromb Hemost 2017;43(6):553–561 Jonathan M. Coutinho 2015 Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for cerebral venous thrombosis. Semin Thromb Hemost 2016;42(6):622–631 Soundarya Selvam 2016 Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost 2017;43(6):572–580 Vincent Muczynski 2016 Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging therapeutic strategies in the treatment of hemophilia A. Semin Thromb Hemost 2017;43(6):581–590 Karen Schreiber 2016 Schreiber K, Breen K, Cohen H, Jacobsen S, Middeldorp S, Pavord S, Regan L, Roccatello D, Robinson SE, Sciascia S, Seed PT, Watkins L, Hunt BJ. HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies. Semin Thromb Hemost 2017;43(6):562–571 Jasmine Wee Ting Tay 2016 Tay J, Tiao J, Hughes Q, Jorritsma J, Gilmore G, Baker R. Circulating microRNA as thrombosis sentinels: caveats and considerations. Semin Thromb Hemost 2018;44(3):206–215 Adi J. Klil-Drori 2016 Klil-Drori AJ, Tagalakis V. Direct oral anticoagulants in end-stage renal disease. Semin Thromb Hemost 2018;44(4):353–363 Ivar van Asten 2017 van Asten I, Schutgens REG, Urbanus RT. Toward flow cytometry based platelet function diagnostics. Semin Thromb Hemost 2018;44(3):197–205 Elodie Laridan 2017 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019;45(1):86–93 Leonardo Pasalic 2017 Blennerhassett R, Curnow J, Pasalic L. Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults. Semin Thromb Hemost 2020;46(3):289–301 Yvonne Brennan 2017 Brennan Y, Favaloro EJ, Curnow J. To maintain or cease non-vitamin k antagonist oral anticoagulants prior to minimal bleeding risk procedures: a review of evidence and recommendations. Semin Thromb Hemost 2019;45(2):171–179 Georgia McCaughan 2017 Submission pending. Mark Schreuder 2018 Schreuder M, Reitsma PH, Bos MHA. Reversal agents for the direct factor Xa inhibitors: biochemical mechanisms of current and newly emerging therapies. Semin Thromb Hemost 2020;46(8):986–998 James McFadyen 2018 Stevens H, McFadyen as in an role and a new Semin Thromb Hemost 2018 The current role of platelet function in clinical Semin Thromb Hemost 2018 J, Sokol J, Simurda T, L, Z, D, Dobrotova M, J, Skornova I, Z, Kubisz P, Stasko J. of von Willebrand disease: current and Semin Thromb Hemost 2018 T, M, I, P, J, Kubisz P, M. and on bleeding and Semin Thromb Hemost 2018 The role of in and Semin Thromb Hemost Elisa 2019 E, M, M, The role of in the of Semin Thromb Hemost Ward 2019 Ward S, The of von Willebrand factor Semin Thromb Hemost Jonathan 2019 J, L, C. and venous on that enable and assessment of the Semin Thromb Hemost 2019 and to for Semin Thromb Hemost 2019 B, K, M. Current in the management of women with von Willebrand disease. Semin Thromb Hemost 2019 D, Rosendaal and the risk of venous thrombosis. Semin Thromb Hemost 2020 therapies for bleeding in a for Semin Thromb Hemost in 2020 C, T, E, J, I, M, S, N, L, K, G, S, P, L, C, R, J, A, P, Venous thromboembolism in patients Semin Thromb Hemost 2020 Submission pending. 2020 Effects of on hemostasis in patients with disease. Semin Thromb Hemost of 2020 Submission pending. Maria 2020 Submission pending. As with these awards, the current of winners a of various of their awardees are on their in or are in their and over into the of their be ([ Fig. 2 is the of our award and a the of Thrombosis and Hemostasis in the the on the of under the of Dr. and Dr. has to as an awarded based on an oral an meeting on of Fig. 2 Young Investigator Award winner ([ Fig. is another of the his and from of in on the of and the of for therapeutic interest in disease into a with the between and began to this in during a he and the role of various in the of in to to he is a in the of and Laboratory this he in the laboratory of Dr. he to be given the to a severe syndrome coronavirus 2 and mechanisms of role in the in his he in many aspects of the is to his current of a with a on Dr. awarded based on an oral presentation for a to of the and this honor with a team the of the and another award Fig. Young Investigator Award winner ([ Fig. is of the Young Investigator also his award for the an award with is a in the of Hemostasis and Thrombosis and After in from he his in the of and Dr. and and a in Dr. awarded the of Award and a laboratory that and to new mechanisms the initiation of Fig. Young Investigator Award winner ([ Fig. is currently as a a from the the of of and of in is currently on understanding the role of von Willebrand factor in and the role of molecular are in the between coagulation and and role in awarded based on an oral presentation the Role of in Fig. Young Investigator Award winner B. ([ Fig. began his in as a an clinical and to an in in which to awarded a from the during his which to a the of his this year. as a in his running a laboratory the role of in clinical Dr. awarded based on an presentation on in during Fig. Young Investigator Award winner B. ([ Fig. is a in thrombosis and has and from the and a clinical in Hematology from the of is a in from the of and is in both and the is of the Society of special interest and with in Dr. awarded based on a abstract from an meeting on the on Pregnancy and Fig. Young Investigator Award winner All award winners were to that selected to an Eberhard F. Mammen Young Investigator and the additional to be awarded an Eberhard F. Mammen Young Investigator award on of this possible by the and of many in and ([ Fig. 2 to have considered and selected for an Eberhard F. Mammen Young Investigator It is to be by an award Dr. Mammen, and in previous years by in the field of also to that in our field our to be recognition to the team this to and for with this and the and to this Finally, would like to the for their award have an on an ([ Fig. is a great honor to be awarded a 2021 Eberhard F. Mammen Young Investigator and that Dr. also selected to this award for our to the editorial team Seminars in Thrombosis and Hemostasis for our on a by which to a team of are all of this Finally, would like to Dr. and Dr. for their to and to on this recognition with to the field of hemostasis and thrombosis in the of Dr. Eberhard ([ Fig. and to be awarded a 2021 Eberhard F. Mammen Young Investigator the recognition that have for on the between and coagulation in would like to the editorial team of Seminars in Thrombosis and Hemostasis for presentation for this award, and Favaloro for the also to and James for the to on this and for their and It is also a recognition of the team by and award to in to this ([ Fig. to an Eberhard F Mammen Young Investigator to have in a laboratory that on the of understanding as it related to and time by as a in a the by and The time with this of and basic an the have from and have to a in to the from in addition to Mark has a and for a also of the to to that in award is with the recent of a and a with we began our in understanding has to to and the B. ([ Fig. and to be awarded an Eberhard F. Mammen Young Investigator The award the of the in the of by and in this would like to the editorial of Seminars in Thrombosis and Hemostasis for this As this is a team would like to the Dr. and Dr. for their in these times and many for and to this ([ Fig. In with previous have the Young Investigator from previous years as well as the outcome of their to Seminars in Thrombosis & Hemostasis as in [ Table 2 ]. The most recent arising publications are also in the list for the of the 2 ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] have mentioned times that most of the from earlier years have in further some of these or the young have of the most popular awards (see [ Table 1 ] for a list of prior editorials on these to to the of the current and Young Investigator Award winners over years. are for Young Investigator and all awardees the best of to the by earlier award winners. Publication Article published All Thieme New